Early research (Phase 1)Ended earlyNCT02630043What this trial is testingTrial of Tolcapone With Oxaliplatin for NeuroblastomaWho this might be right forNeuroblastoma Giselle Sholler 5
Early research (Phase 1)Study completedNCT02748135What this trial is testingTB-403 in Pediatric Subjects With Relapsed or Refractory MedulloblastomaWho this might be right forRelapsed or Refractory Medulloblastoma (MB), Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS) Oncurious NV 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948994What this trial is testingA Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Diagnosed High-risk or Relapsed/Refractory NeuroblastomaWho this might be right forNeuroblastomaGD2 AntibodyAutologous NK Cell Guangzhou Women and Children's Medical Center 15
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Early research (Phase 1)Looking for participantsNCT06751134What this trial is testingChimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory NeuroblastomaWho this might be right forNeuroblastoma, Recurrent, Refractory Nanjing Children's Hospital 12
Testing effectiveness (Phase 2)Study completedNCT06438614What this trial is testingNaxitamab , Granulocyte Macrophage Colony Stimulating Factor For Patients With Relapsed /Refractory , Soft Tissue or Anti GD2 Immunotherapy Refractory NeuroblastomaWho this might be right forRefractory NeuroblastomaSoft Tissue Cancer Fundació Sant Joan de Déu 47
Large-scale testing (Phase 3)Study completedNCT00003883What this trial is testingItraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow TransplantationWho this might be right forCancer Fred Hutchinson Cancer Center 578
Early research (Phase 1)Ended earlyNCT04751383What this trial is testingTesting the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed OsteosarcomaWho this might be right forHigh Risk NeuroblastomaRecurrent NeuroblastomaRecurrent Osteosarcoma+2 more National Cancer Institute (NCI) 12
Early research (Phase 1)UnknownNCT05338541What this trial is testingTucidinostat Plus Etoposide in the Treatment of Neuroblastoma in Childhood.Who this might be right forNeuroblastoma in Children Yizhuo Zhang 30
Large-scale testing (Phase 3)Study completedNCT00004230What this trial is testingCaptopril in Treating Patients Undergoing Bone Marrow or Stem Cell TransplantationWho this might be right forCancer Northwestern University 35
Early research (Phase 1)Study completedNCT00867568What this trial is testingTPI 287 in Patients With Refractory or Recurrent Neuroblastoma or MedulloblastomaWho this might be right forNeuroblastomaMedulloblastomaRelapse Giselle Sholler 18
Testing effectiveness (Phase 2)Looking for participantsNCT06721689What this trial is testingPEEL-224, Vincristine and Temozolomide in Pediatric Solid TumorsWho this might be right forRefractory Solid TumorsRelapsed Solid TumorsRelapsed Neuroblastoma+3 more Theodore Laetsch 59
Testing effectiveness (Phase 2)Study completedNCT00293319What this trial is testing131 I-MIBG in Treating Patients With Refractory or Relapsed NeuroblastomaWho this might be right forNeuroblastoma University of California, San Francisco 164
Early research (Phase 1)Study completedNCT01048892What this trial is testingSeneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesWho this might be right forAdrenocortical CarcinomaGastrointestinal Carcinoid TumorKidney Cancer+3 more Children's Oncology Group 22
Not applicableStudy completedNCT00049465What this trial is testingStandard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for CancerWho this might be right forCancer Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06607692What this trial is testingStudy in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).Who this might be right forSolid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more Fundación de investigación HM 25
Early research (Phase 1)Active Not RecruitingNCT03635632What this trial is testingC7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)Who this might be right forRelapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more Baylor College of Medicine 94
Early research (Phase 1)Study completedNCT02909777What this trial is testingTrial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or LymphomaWho this might be right forLymphomaNeuroblastomaBrain Tumor+1 more Dana-Farber Cancer Institute 26
Early research (Phase 1)Study completedNCT02030964What this trial is testingN2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/TopotecanWho this might be right forNeuroblastoma New Approaches to Neuroblastoma Therapy Consortium 30
Early research (Phase 1)Study completedNCT01453283What this trial is testingTabectedin to Treat Children and Adolescents With CancerWho this might be right forSolid Tumors National Cancer Institute (NCI) 12